Marex Group »

Denali Therapeutics shares owned by Marex Group

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Marex Group from 13F filings

Historical chart of Marex Group investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by Marex Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by Marex Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $4.2M 291k 14.52
2025-06-30 $3.7M 262k 13.99

More positions owned by Marex Group

Tesla Motors Call Option (TSLA)
Mastercard Incorporated Cl A (MA)
Booking Holdings (BKNG)
Microsoft Corporation Call Option (MSFT)
Strategy Cl A New (MSTR)
UnitedHealth (UNH)
NVIDIA Corporation Call Option (NVDA)
Eli Lilly & Co. (LLY)
Valkyrie Bitcoin (BRRR)
Apple (AAPL)
Netflix (NFLX)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Meta Platforms Cl A (META)
Broadcom Call Option (AVGO)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)

View all positions for Marex Group

Top funds holding Denali Therapeutics

BlackRock
Vanguard Group
Baillie Gifford & Co
FMR
T. Rowe Price Investment Management
Ubs Global Asset Management Americas
State Street Corporation
Temasek Holdings
Capital Research Global Investors
Baker Bros. Advisors
Alliancebernstein
Geode Capital Management
Crestline Management
Holocene Advisors
Point72 Asset Management

View all funds holding Denali Therapeutics